Literature DB >> 28412912

The Socioeconomic Effects of Uncontrolled Hypertension.

Kostas Athanasakis1.   

Abstract

BACKGROUND: Hypertension (HT), albeit a modifiable risk factor of cardiovascular morbidity and mortality, remains one of the main contributors to the total disease burden internationally and, thus, inevitably one of the basic cost drivers in healthcare systems.
CONCLUSION: Taking the above into account, this brief narrative review aims at presenting the main findings of the international health economics literature on HT with regards to four key areas: a) the costs attributable to HT, b) the effects of HT on patient well-being, c) the cost-effectiveness of pharmaceutical interventions against high blood pressure, and, d) the costs and benefits of preventive measures against HT. Bearing in mind the available evidence on disease costs and the efficiency of interventions, HT must constitute a primary objective of modern health policy, internationally. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Hypertension; cost; cost-effectiveness; health economics; health-related quality of life

Mesh:

Substances:

Year:  2017        PMID: 28412912     DOI: 10.2174/1570161115666170413145125

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  2 in total

1.  Analysis of Association of Occupational Physical Activity, Leisure-Time Physical Activity, and Sedentary Lifestyle with Hypertension according to the Adherence with Aerobic Activity in Women Using Korea National Health and Nutrition Examination Survey 2016-2017 Data.

Authors:  Mikyung Ryu; Sol Lee; Ho Gym; Weon-Chil Baek; Heejin Kimm
Journal:  Int J Hypertens       Date:  2020-02-14       Impact factor: 2.420

2.  State earned income tax credits and general health indicators: A quasi-experimental national study 1993-2016.

Authors:  Erin R Morgan; Heather D Hill; Stephen J Mooney; Frederick P Rivara; Ali Rowhani-Rahbar
Journal:  Health Serv Res       Date:  2020-07-08       Impact factor: 3.734

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.